HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ogalvibart

Also Known As:

BMS-986414; BMS986414; C135 LS; C135-LS

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Allen, A Mark: 1 article (01/2021)
2.	Ardeshir, Amir: 1 article (01/2021)
3.	Aye, Pyone Pyone: 1 article (01/2021)
4.	Beddingfield, Brandon J: 1 article (01/2021)
5.	Bieniasz, Paul D: 1 article (01/2021)
6.	Blair, Robert V: 1 article (01/2021)
7.	Carias, Ann M: 1 article (01/2021)
8.	Dang, Que: 1 article (01/2021)
9.	Deere, Jesse D: 1 article (01/2021)
10.	Doyle-Meyers, Lara A: 1 article (01/2021)

Related Diseases

1.

01/01/2021 - "The rhesus macaque model of COVID-19 was utilized to test the added benefit of combinatory parenteral administration of two high-affinity anti-SARS-CoV-2 monoclonal antibodies (mAbs; C144-LS and C135-LS) expressly developed to neutralize the virus and modified to extend their pharmacokinetics. "
01/01/2021 - "We investigated the therapeutic efficacy of a combination of two potent monoclonal antibodies, C135-LS and C144-LS that carry half-life extension mutations, in the rhesus macaque model of COVID-19. "

Related Drugs and Biologics

1.	Monoclonal Antibodies
2.	crexavibart